ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
Aclarion Inc

Aclarion Inc (ACON)

4.67
-0.69
(-12.87%)
終了 2月11日 6:00AM
4.52
-0.15
( -3.21% )
プレマーケット: 7:01PM

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

主要統計と詳細

通貨
4.52
買値
4.52
売値
4.71
出来高
1,232
0.00 日の範囲 0.00
0.0275 52 週間の範囲 20.84
時価総額
前日終値
4.67
始値
-
時刻
2
@
4.65
最終取引時間
19:41:13
財務取引量
-
VWAP
-
平均取引量 (3 か月)
39,221,550
発行済株式数
131,940
配当利回り
-
PER
-0.13
1 株当たり利益 (EPS)
-37.22
歳入
75k
純利益
-4.91M

Aclarion Inc について

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments.

セクター
Medical Laboratories
業界
Medical Laboratories
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
Aclarion Inc is listed in the Medical Laboratories sector of the ナスダック市場 with ticker ACON. The last closing price for Aclarion was US$4.67. Over the last year, Aclarion shares have traded in a share price range of US$ 0.0275 to US$ 20.84.

Aclarion currently has 131,940 shares in issue. The market capitalisation of Aclarion is US$616,159.80 . Aclarion has a price to earnings ratio (PE ratio) of -0.13.

ACON 最新ニュース

Aclarion Announces Northwestern Medicine as First CLARITY Trial Site

Northwestern Medicine is a global leader in clinical trial research, including spine CLARITY is a randomized study designed to demonstrate Nociscan’s ability to improve surgical outcomes while...

Aclarion Announces CLARITY Trial for Nociscan Now Fully Funded

The Company has secured nearly $20 million in gross proceeds in 2025 ensuring complete funding for its pivotal CLARITY trial CLARITY is a prospective, randomized, multicenter study to validate...

Aclarion to Showcase Groundbreaking NOCISCAN Technology at the Selby Spine Conference

Dr. Sigurd Berven to Highlight NOCISCAN Capabilities, Combining MR Spectroscopy and Augmented Intelligence (AI) NOCISCAN as New Gold Standard in Identifying a Source of Discogenic Pain...

Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash

Article Focuses on how Leading Physicians are Incorporating Nociscan Into Their Clinical Practices for Chronic Low Back Pain Patients MAGNETOM Flash is a Peer-to-Peer Magazine Published by...

Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit

Fireside Chat Scheduled for 2:00 PM ET on October 15, 2024 BROOMFIELD, Colo., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare...

Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes

Modic Changes (MC) are MRI Findings Associated With Endplate Damage, Neoinnervation, and Chronic Low Back Pain (cLBP) MR Spectroscopy (MRS) Measurement of Intradiscal Propionic Acid (PA) can...

PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology

NEW YORK, Sept. 13, 2024 (GLOBE NEWSWIRE) -- PRISM MarketView presents an exclusive Q&A with Brent Ness, CEO and Director of Aclarion, Inc. (Nasdaq: ACON). As a disruptive healthcare...

Aclarion Provides Corporate Update on Nociscan AI Technology Milestones

Successful milestones achieved and upcoming include peer-reviewed publications, commercial agreements, and payer coverage decisions Progressing with proven path toward standard of care addressing...

Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial

Initial LIFEHAB Enrolled Patients Receive Nociscan Exams to Help Evaluate How Biomarkers in the Discs of the Lumbar Spine Correspond With Treatment Response LIFEHAB is a Randomized Controlled...

Aclarion Added to PRISM Emerging Medical Devices Index

Company's industry-first technology addresses chronic low back painAclarion secured its first commercial agreement with Michigan's Sheridan Community HospitalPRISM Emerging Medical Devices Index...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-3.42-43.07304785897.948.774.5117066366.63651393CS
44.41124054.411764710.108820.840.0275977761420.09862424CS
124.35052566.666666670.169520.840.0275392215500.1290326CS
264.2411520.071684590.27920.840.0275175798110.13039602CS
522.67144.3243243241.8520.840.027596524870.15166555CS
156-41.88-90.258620689746.464.80.027540163412.50225965CS
260-41.88-90.258620689746.464.80.027540163412.50225965CS

ACON - Frequently Asked Questions (FAQ)

What is the current Aclarion share price?
The current share price of Aclarion is US$ 4.52
How many Aclarion shares are in issue?
Aclarion has 131,940 shares in issue
What is the market cap of Aclarion?
The market capitalisation of Aclarion is USD 616.16k
What is the 1 year trading range for Aclarion share price?
Aclarion has traded in the range of US$ 0.0275 to US$ 20.84 during the past year
What is the PE ratio of Aclarion?
The price to earnings ratio of Aclarion is -0.13
What is the cash to sales ratio of Aclarion?
The cash to sales ratio of Aclarion is 8.22
What is the reporting currency for Aclarion?
Aclarion reports financial results in USD
What is the latest annual turnover for Aclarion?
The latest annual turnover of Aclarion is USD 75k
What is the latest annual profit for Aclarion?
The latest annual profit of Aclarion is USD -4.91M
What is the registered address of Aclarion?
The registered address for Aclarion is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
What is the Aclarion website address?
The website address for Aclarion is www.aclarion.com
Which industry sector does Aclarion operate in?
Aclarion operates in the MEDICAL LABORATORIES sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
OCEAOcean Biomedical Inc
US$ 0.2688
(81.62%)
66.35M
VSTEVast Renewable Ltd
US$ 1.115
(61.59%)
13.97M
NOEMCO2 Energy Transition Corporation
US$ 15.76
(59.68%)
4
BBGIBeasley Broadcast Group Inc
US$ 12.48
(59.18%)
4
BSBKBogota Financial Corporation
US$ 12.29
(55.18%)
9
AIRJAirJoule Technologies Corporation
US$ 5.21
(-41.00%)
1
PRAAPRA Group Inc
US$ 14.01
(-39.69%)
7
CFSBCFSB Bancorp Inc
US$ 5.00
(-36.06%)
223
FLNCFluence Energy Inc
US$ 8.38
(-35.88%)
323.38k
SLNGStabilis Solutions Inc
US$ 5.12
(-33.16%)
5
CYNCYNGN Inc
US$ 0.287
(55.39%)
120.24M
OCEAOcean Biomedical Inc
US$ 0.2664
(80.00%)
66.46M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0903
(30.87%)
29.47M
CLEUChina Liberal Education Holdings Ltd
US$ 0.1432
(31.98%)
25.53M
VSTEVast Renewable Ltd
US$ 1.12
(62.32%)
13.98M

ACON Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock